Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Sarepta Therapeutics
Pharma
Sarepta to test Elevidys with immunosuppressive regimen
Sarepta will study its gene therapy Elevidys with the immunosuppressant sirolimus in non-ambulatory patients with Duchenne muscular dystrophy.
Zoey Becker
Nov 25, 2025 2:19pm
FDA limits Elevidys gene therapy to ambulatory Duchenne patients
Nov 14, 2025 3:20pm
Catalent cuts 77 more jobs in Maryland
Nov 10, 2025 4:18pm
Sarepta, despite key trial flop, will seek full nod for DMD meds
Nov 4, 2025 7:56am
Sarepta extends $700M debt to 2030 amid Elevidys uncertainty
Aug 21, 2025 10:52am
Sarepta shares more Elevidys safety data
Aug 18, 2025 11:32am
